Workgroup report: Implementing a national occupational reproductive research agenda - Decade one and beyond

Environmental Health Perspectives

Volumn 114, Issue 3, 2006, Pages 435-441

  Lawson, Christina C ^a   Grajewski, Barbara ^a   Daston, George P ^b   Frazier, Linda M ^c   Lynch, Dennis ^a   McDiarmid, Melissa ^d   Murono, Eisuke ^a   Perreault, Sally D ^e   Robbins, Wendie A ^f   Ryan, Megan A K ^g   Shelby, Michael ^h   Whelan, Elizabeth A ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b PROCTER AND GAMBLE COMPANY   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Department of Defense   (United States)

^h NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Communication; Environmental exposure; Occupational exposure; Reproduction; Research design; Risk factors

Indexed keywords

1 CHLORO 4 NITROBENZENE; 2 BUTOXYETHANOL; 4,4' ISOPROPYLIDENEDIPHENOL; ACRYLAMIDE; BORIC ACID; CHLORINATED HYDROCARBON; ETHYLENE GLYCOL; FUNGICIDE; N,N DIMETHYLFORMAMIDE; OXALIC ACID; PHTHALIC ACID DIBUTYL ESTER; TITANIUM DIOXIDE; TRICRESYL PHOSPHATE; ZINC OXIDE;

ARTICLE; BIRTH DEFECT; BREAST CANCER; CANCER RISK; CHILDHOOD CANCER; CONGENITAL MALFORMATION; DEVELOPMENTAL DISORDER; ENDOCRINE DISEASE; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION PROFILING; HEALTH CARE PLANNING; HEALTH PROGRAM; HIGH THROUGHPUT SCREENING; HUMAN; INFERTILITY; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; MEDICAL INFORMATION SYSTEM; MEDICAL RESEARCH; MENOPAUSE; NANOPARTICLE; NONHUMAN; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL HEALTH; OCCUPATIONAL SAFETY; OCCUPATIONAL TOXICOLOGY; PATHOGENESIS; PRACTICE GUIDELINE; PREDICTION; PREGNANCY OUTCOME; PREMATURITY; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REPRODUCTIVE HEALTH; REPRODUCTIVE TOXICITY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEX DIFFERENTIATION; SHIFT WORKER; WHOLE BODY VIBRATION; WORKING TIME; WORKPLACE;

DRUG TOXICITY; HAZARDOUS SUBSTANCES; HUMANS; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; REPRODUCTION; REPRODUCTIVE MEDICINE; RESEARCH; UNITED STATES;

EID: 33644769219     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.8458     Document Type: Article

References (85)

1. ACGIH Worldwide. 2004. 2004 TLVs and BEIs. Cincinnati, OH:American Conference of Governmental Industrial Hygienists Worldwide, 77-79.
2. Akerstedt T. 1990. Psychological and psychophysiological effects of shift work. Scand J Work Environ Health 16(suppl 1):67-73.
3. American Medical Association, Council on Scientific Affairs. 1999. Health literacy. JAMA 281:552-557.
4. ANSI. 2004. Material Safety Data Sheets - Preparation. ANSI Z400. New York: American National Standards Institute Inc., 8-10.
5. Blair RM, Fang H, Branham WS, Hass BS, Dial SL, Moland CL, et al. 2000. The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands. Toxicol Sci 54:138-153.
6. Blangero J. 2004. Localization and identification of human quantitative trait loci: king harvest has surely come. Curr Opin Genet Dev 14:233-240.
7. Boyer EL. 1990. Scholarship Reconsidered: Priorities of the Professorate. The Carnegie Foundation for the Advancement of Teaching. Princeton, NJ:Jossey-Bass.
8. Bradbury S, Kamenska V, Schmeider P, Anley G, Mekenyan O. 2000. A computationally based identification algorithm for estrogen receptor ligands. Part 1: predicting hERalpha binding affinity. Toxicol Sci 58:253-269.
9. Brookes AJ. 1999. The essence of SNPs. Gene 23A:177-186.
10. Brown-Woodman PD, Webster WS, Picker K, Huq F. 1994. In vitroassessment of individual and interactive effects of aromatic hydrocarbons on embryonic development of the rat. Reprod Toxicol 8:121-135.
11. Burke W, Atkins D, Gwinn M, Guttmacher A, Haddow J, Lau J, et al. 2002. Genetic test evaluation: information needs of clinicians, policy makers, and the public. Am J Epidemiol 156:311-318.
12. Cardinale M, Pope MH. 2003. The effects of whole body vibration on humans: dangerous or advantageous? Acta Physiol Hung 90(3):195-206.
13. Cargill W, Altshuler D, Ireland J, Ardie K, Patil N, Shaw N, et al. 1999. Characterization of single nucleotide polymorphisms in coding regions of human genes. Nat Genet 22:231
14. CDC (Centers for Disease Control and Prevention). 1995. Economic costs of birth defects and cerebral palsy B United States, 1992. MMWR Morb Mortal Wkly Rep 44:694-699.
15. CERHR (Center for the Evaluation of Risks to Human Reproduction). 2000. NTP-CERHR Expert Panel Report on Di(2-ethylhexyl)phthalate. NTP-CERHR-DEHP-00. Research Triangle Park, NC:National Toxicology Program, U.S. Department of Health and Human Services.
16. CERHR (Center for the Evaluation of Risks to Human Reproduction). 2004. NTP-CERHR expert panel report on the reproductive and developmental toxicity of 1-bromopropane. Reprod Toxicol 18:157-188.
17. CERHR (Center for the Evaluation of Risks to Human Reproduction). 2005a. NTP-CERHR Monograph on the Reproductive and Developmental Effects of Acrylamide. NIH Publ No. 05-4472. Research Triangle Park, NC:National Toxicology Program, U.S. Department of Health and Human Services.
18. CERHR. 2005b. Homepage. Research Triangle Park, NC:Center for the Evaluation of Risks to Human Reproduction. Available: http://cerhr.niehs.nih.gov/ [accessed 19 October 2005].
19. Chen D, Hu Y, Chen C, Yang F, Fang Z, Wang L, et al. 2004. Polymorphisms of the paraoxonase gene and the risk of preterm delivery. Epidemiology 15:466-470.
20. Chen D, Hu Y, Yang F, Li Z, Wu B, Fang B, et al. 2005. Cytochrome P450 gene polymorphisms and risk of low birth weight. Genet Epidemiol 28:368-375.
21. Colvin V. 2003. The potential environmental impact of engineered nanomaterials. Nat Biotechnol 21:1166-1170.
22. Colvin V. 2004. Sustainability for nanotechnology. Scientist 18:26-27.
23. Connor TH, Anderson RW, Sessink PJ, Broadfield L, Power LA. 1999. Surface contamination with antineoplastic agents in six cancer treatment centers in Canada and the United States. Am J Health Syst Pharm 56:1427-1432.
24. Dreher KL. 2004. Health and environmental impact of nanotechnology: toxicological assessment of manufactured nanoparticles. Toxicol Sci 77:3-5.
25. EDSTAC. 1998. Recommendations to U.S. EPA on Endocrine Disrupter Screening and Testing. Endocrine Disruptor Screening and Testing Advisory Committee. Available: http://www.epa.gov/scipoly/oscpendo/edspoverview/finalrpt.htm [accessed 17 October 2005].
26. Fang H, Tong W, Branham WS, Moland CL, Dial SL, Hong H, et al. 2003. Study of 202 natural, synthetic and environmental chemicals for binding to the androgen receptor. Chem Res Toxicol 16:1338-1358.
27. Fertuck KC, Eckel JE, Gennings C, Zacharewski TR. 2003. Identification of temporal patterns of gene expression in the uterus of immature, ovariectomized mice following exposure to ethinylestradiol. Physiol Genomics 15:127-141.
28. Frazier LM, Grainger DA. 2003. Shift work and adverse reproductive outcomes among men and women. Clin Occup Environ Med 3:279-292.
29. Gordon T, Kannel WB, Hjortland MC, McNamara PM. 1978. Menopause and coronary heart disease: the Framingham study. Ann Intern Med 89:157-161.
30. Grajewski B, Coble J, Frazier L, McDiarmid M. 2005. Occupational exposures and reproductive health: 2003 Teratology Society meeting symposium summary. Birth Defects Res B Dev Reprod Toxicol 74:157-163.
31. Grajewski B, Nguyen MM, Whelan EA, Cole RJ, Hein MJ. 2003. Measuring circadian rhythm disruption in female flight attendants. Scand J Work Environ Health 29:337-346
32. Hilscherova K, Jones PD, Gracia T, Newsted JL, Zhang X, Sanderson JT, et al. 2004. Assessment of the effects of chemicals on the expression of ten steroidogenic genes in the H295R cell line using real-time PCR. Toxicol Sci 81:78-89.
33. Hirschorn JN, Daly MJ. 2005. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6:95-108.
34. Holmes LB. 1997. Impact of the detection and prevention of developmental abnormalities in human studies. Reprod Tox 11:267-269.
35. Hunter DJ. 2005. Gene-environment interactions in human diseases. Nat Rev Genet 6:287-298.
36. ICCVAM. 2003. Evaluation of In VitroTest Methods For Detecting Potential Endocrine Disruptors: Estrogen Receptor and Androgen Receptor Binding and Transcriptional Activation Assays. NIH Publ No. 03-4503. Research Triangle Park, NC:Interagency Coordinating Committee on the Validation of Alternative Methods, National Toxicology Program.
37. International Human Genome Sequence Consortium. 2000. Initial sequencing and analysis of the human genome. Nature 409:860-921.
38. International SNP Map Working Group. 2001. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409:928-933.
39. Ioannidis JPA, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. 2001. Replication validity of genetic association studies. Nat Genet 29:306-309.
40. Khan IY, Lakasing L, Poston L, Nicolaides KH. 2003. Fetal programming for adult disease: where next? J Matern Fetal Neonatal Med 13:292-299.
41. Kolp P, Sattler G, Blayney M, Sherwood T. 1993. Comprehensibility of material safety data sheets. Am J Ind Med 23:135-141.
42. Kurina LM, Gulati M, Everson-Rose SA, Chung PJ, Karavolos K, Cohen NJ. 2004. The effect of menopause on grip and pinch strength: results from the Chicago, Illinois, site of the Study of Women's Health across the Nation. Am J Epidemiol 160:484-491.
43. Lau C, Rogers JM. 2004. Embryonic and fetal programming of physiological disorders in adulthood. Birth Defects Res C Embryo Today 72:300-312.
44. Lawson CC, Schnorr TM, Daston GP, Grajewski B, Marcus M, McDiarmid M, et al. 2003. An occupational reproductive research agenda for the third millennium. Environ Health Perspect 111:584-592.
45. Lindquist O, Bengtsson C, Hansson T, Roos B. 1979. Age at menopause and its relation to osteoporosis. Maturitas 1:175-181.
46. Lisabeth L, Harlow S, Qaqish B. 2004. A new statistical approach demonstrated menstrual patterns during the menopausal transition did not vary by age at menopause. J Clin Epidemiol 57:484-496.
47. Mattes WB, Pettit SD, Sansone S-A, Bushel PR, Waters MD. 2004. Database development in toxicogenomics: issues and efforts. Environ Health Perspect 112:495-505.
48. Meador V, Jordan W, Zimmerman J. 2002. Increasing throughput in lead optimization in vivotoxicity screens. Curr Opin Drug Discov Dev 5:72-78.
49. Mekenyan OG, Kamenska V, Schmeider PK, Ankley GT, Bradbury SP. 2000. A computationally based identification algorithm for estrogen receptor ligands. Part 2: evaluation of hERalpha binding affinity model. Toxicol Sci 58:270-281.
50. Moggs JG, Ashby J, Tinwell H, Lim FL, Moore DJ, Kimber I, et al. 2004. The need to decide if all estrogens are intrinsically similar. Environ Health Perspect 112:1137-1142.
51. Montgomery KG, Gertig DM, Baxter SW, Milne RL, Dite GS, McCredie MRE, et al. 2003. The HER2 I655V polymorphism and risk of breast cancer in women < age 40 years. Cancer Epidemiol Biomark Prevent 12:1109-1111.
52. Moore JA and Expert Scientific Committee. 1997. An assessment of boric acid and borax using the IEHR evaluative process for assessing human developmental and reproductive toxicity of agents. Reprod Toxicol 11:123-160.
53. Moorman WJ, Ahlers HW, Chapin RE, Daston GP, Foster PMD, Kavlock RJ, et al. 2000. Prioritization of NTP reproductive toxicants for field studies. Reprod Toxicol 14:293-301.
54. Naciff JM, Jump ML, Torontali SM, Carr GJ, Tiesman JP, Overmann GJ, et al. 2002. Gene expression profile induced by 17a-ethinyl estradiol, bisphenol A, and genistein in the developing female reproductive system of the rat. Toxicol Sci 68:184-199.
55. Naciff JM, Overmann GJ, Torontali SM, Carr GJ, Tiesman JP, Daston GP. 2004. Impact of the phytoestrogen content of laboratory animal feed on the gene expression profile of the reproductive system in the immature female rat. Environ Health Perspect 112:1519-1526.
56. Naciff JM, Overmann GJ, Torontali SM, Carr GJ, Tiesman JP, Richardson BD, et al. 2003. Gene expression profile induced by 17 alpha-ethynyl estradiol in the prepubertal female reproductive system of the rat. Toxicol Sci 72:314-330.
57. National Children's Study. 2005. The National Children's Study [Homepage]. Washington, DC:U.S. Department of Health and Human Services/U.S. Environmental Protection Agency. Available: http://www.nationalchildrensstudy.gov/ [accessed 19 October 2005].
58. National Research Council. 2002. Small Wonders, Endless Frontiers: A Review of the National Nanotechnology Initiative. Washington, DC:National Academies Press.
59. National Work Group on Literacy and Health. 1998. Communicating with patients who have limited literacy skills. J Fam Pract 46:168-176.
60. Nellemann C, Dalgaard M, Lam HR, Vinggaard AM. 2003. The combined effects of vinclozolin and procymidone do not deviate from expected additivity in vitro and in vivo. Toxicol Sci 71:251-262.
61. NIOSH (National Institute for Occupational Safety and Health). 2004. Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings. NIOSH Publ No. 2004-165. Washington, DC:U.S. Government Printing Office.
62. NIOSH (National Institute for Occupational Safety and Health). 2005. Mixed Exposures Research Agenda: A Report by the NORA Mixed Exposures Team. NIOSH Publ No. 2005-106. Washington, DC:U.S. Government Printing Office.
63. O'Hara MF, Charlap JH, Craig RC, Knudsen TB. 2002. Mitochondrial transduction of ocular teratogenesis during methylmercury exposure. Teratology 65:131-144.
64. OSHA. 1986. Guidelines for Antineoplastic (Cytotoxic) Drugs. OSHA Publ 8.1.1. Washington, DC:Occupational Safety and Health Administration.
65. OSHA. 1995. Controlling Occupational Exposure to Hazardous Drugs. Washington, DC:Occupational Safety and Health Administration.
66. Perkel JM. 2003. Nanoscience is out of the bottle. Scientist 17:20-23.
67. Perkel JM. 2004. The ups and downs of nanobiotech. Scientist 18:14-18.
68. Roegge CS, Wang VC, Powers BE, Klintsova AY, Villareal S, Greenough WT, et al. 2004. Motor impairment in rats exposed to PCBs and methylmercury during early development. Toxicol Sci 77:315-324.
69. Rogers EH, Hunter ES, Rosen MB, Rogers JM, Lau C, Hartig PC, et al. 2003. Lack of evidence for intergenerational reproductive effects due to prenatal and postnatal undernutrition in the female CD-1 mouse. Reprod Toxicol 17:519-525.
70. Royal Society and Royal Academy of Engineering. 2004. Nanoscience and nanotechnologies: opportunities and uncertainties. London:Royal Society. Available: http://www.royalsoc.ac.uk/document.asp?id=2023/ [accessed 27 January 2006].
71. Selevan SG, Rice DC, Hogan KA, Euling SY, Pfahles-Hutchens A, Bethel J. 2003. Blood lead concentration and delayed puberty in girls. N Engl J Med 348:1527-1536.
72. Silk JC. 2003. Development of a globally harmonized system for hazard communication. Int J Hyg Environ Health 206:447-452.
73. Silva MJ, Barr DB, Reidy JA, Malek NA, Hodge CC, Caudill SP, et al. 2004. Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environ Health Perspect 112:331-338.
74. Simmons JE, Richardson SD, Speth TF, Miltner RJ, Rice G, Schenck KM, et al. 2002. Development of a research strategy for integrated technology-based toxicological and chemical evaluation of complex mixtures of drinking water disinfection byproducts. Environ Health Perspect 110(suppl 6):1013-1024.
75. Singh SM, Gauthier S, Labrie F. 2000. Androgen receptor antagonists (antiandrogens): structure-activity relationships. Curr Med Chem 7:211-247.
76. Tabor HK, Risch NJ, Meyers RM. 2002. Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 3:1-7.
77. Trichopoulos D, MacMahon B, Cole P. 1972. Menopause and breast cancer risk. J Natl Cancer Inst 48:605-613.
78. Tully DB, Luft JC, Rockett JC, Ren H, Schmid JE, Wood CR, et al. 2005. Reproductive and genomic effects in testes from mice exposed to the water disinfectant byproduct bromochloroacetic acid. Reprod Toxicol 19:353-366.
79. UN Economic Commission for Europe. 2003. The Globally Harmonized System of Classification and Labelling of Chemicals. Geneva:United Nations Economic Commission for Europe, 175-186, 307-321.
80. U.S. Census Bureau. 2003a. Table H5. Women 15 to 44 years Old Who Have Had a Child in the Last Year and Their Percentage in the Labor Force: Selected Years, June 1976 to Present. Washington, DC:U.S. Census Bureau. Available: http://www.census.gov/population/socdemo/fertility [accessed 15 June 2005].
81. U.S. Census Bureau. 2003b. Statistical Abstract of the United States: 2003. Table 572. Civilian Labor Force_Percent Distribution by Sex and Age: 1980 to 2003. Washington, DC:U.S. Census Bureau. Available: http://www.census.gov/prod/2004pubs/04statab/labor.pdf [accessed 15 June 2005].
82. U.S. EPA. 1998. Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC); Final Report. Washington, DC:U.S. Environmental Protection Agency. Available: http://www.epa.gov/oscpmont/oscpendo/edspoverview/finalrpt.htm [accessed 15 December 2004].
83. U.S. EPA. 2005. Voluntary Children's Chemical Evaluation Program (VCCEP). Washington, DC:U.S. Environmental Protection Agency. Available: http://www.epa.gov/chemrtk/vccep/index.htm [accessed 19 October 2005].
84. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Suton GG, et al. 2001. The sequence of the human genome. Science 291:1304-1351.
85. Waring JF, Ulrich RG. 2000. The impact of genomics-based technologies on drug safety evaluation. Annu Rev Pharmacol Toxicol 40:335-352.